Efficacy of Methimazole Dosing Algorithm
Reason given: Unable to reach recruiting goals
Key facts
- Where
- Chicago, United StatesSee the site
Where in United States
- Cook County HealthChicago, United StatesNo longer taking part
Trial details
- Who runs it
- Cook County Health
- Trial code
- NCT05964452
- Record updated
- 27 December 2024
- Original description
To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.Read full original descriptionShow less
The Efficacy of Cook County Health's Methimazole Dosing Algorithm in the Setting of Ne Onset Graves' Hyperthyroidism
To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.
Inclusion: Non-pregnant adults (>18 years of age) with new diagnosis of Graves' Disease (elevated free T4, Free T3, low or suppressed TSH, positive TSI and or thyroid eye disease) and; either drug naïve or who have been initiated on MMI within previous 4-6 weeks per CCH algorithm.
Exclusion: Pregnant patients; hyperthyroidism due to other causes, example - Toxic Multinodular Goiter, Iodine induced thyrotoxicosis, etc; Graves patients who present with atrial fibrillation, CHF or other end organ damage.